ABSTRACT
Intracellular bacterial pathogens have evolved a plethora of strategies to invade eukaryotic cells. By manipulating host signaling pathways, in particular vesicular trafficking, these microbes subvert host functions to promote their internalization and to establish an intracellular niche. During these events, host endomembrane compartments are dynamically reorganized. Shigella flexneri, the causative agent of bacillary dysentery, recruits components of the host recycling pathway and the exocyst of non-phagocytic enterocytes in the vicinity of its entry site to facilitate its access to the host cytosol. These factors are either dynamically tethered to in situ formed macropinosomes or to the bacteria-containing vacuole itself. The underlying interactions cannot readily be monitored as individual bacterial infection events take place without synchronicity using cellular infection models. Therefore, time-resolved screens by fluorescence microscopy represent a powerful tool for the study of host subversion. Such screens can be performed with libraries of fluorescently tagged host factors. Using the cytosolic pathogenic agent Shigella flexneri as a model, we provide detailed protocols for such medium-to-high throughput multidimensional imaging screening of the dynamic host-pathogen cross talk. Our workflow is designed to be easily adapted for the study of different host factor libraries and different pathogen models.
Subject(s)
Dysentery, Bacillary , Vacuoles , Bacterial Proteins/metabolism , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Endosomes/metabolism , Host-Pathogen Interactions , Humans , Microscopy, Fluorescence , Shigella flexneri , Vacuoles/metabolismABSTRACT
Shigella sonnei is the emerging pathogen globally, as it is the second common infectious species of shigellosis (bloody diarrhoea) in low- and middle-income countries (LMICs) and the leading one in developed world. The multifactorial processes and novel mechanisms have been identified in S. sonnei, that are collectively playing apart a substantial role in increasing its prevalence, while replacing the S. flexneri and other Gram-negative gut pathogens niche occupancy. Recently, studies suggest that due to improvement in sanitation S. sonnei has reduced cross-immunization from Plesiomonas shigelliodes (having same O-antigen as S. sonnei) and also found to outcompete the two major species of Enterobacteriaceae family (Shigella flexneri and Escherichia coli), due to encoding of type VI secretion system (T6SS). This review aimed to highlight S. sonnei as an emerging pathogen in the light of recent research with pondering aspects on its epidemiology, transmission, and pathogenic mechanisms. Additionally, this paper aimed to review S. sonnei disease pattern and related complications, symptoms, and laboratory diagnostic techniques. Furthermore, the available treatment reigns and antibiotic-resistance patterns of S. sonnei are also discussed, as the ciprofloxacin and fluoroquinolone-resistant S. sonnei has already intensified the global spread and burden of antimicrobial resistance. In last, prevention and controlling strategies are briefed to limit and tackle S. sonnei and possible future areas are also explored that needed more research to unravel the hidden mysteries surrounding S. sonnei.
Subject(s)
Drug Resistance, Bacterial , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/microbiology , Shigella sonnei/drug effects , Shigella sonnei/pathogenicity , Anti-Bacterial Agents/pharmacology , Ciprofloxacin/pharmacology , Dysentery, Bacillary/diagnosis , Dysentery, Bacillary/pathology , Escherichia coli/drug effects , Fluoroquinolones/pharmacology , Humans , Shigella flexneri/drug effects , Type VI Secretion Systems/physiologySubject(s)
Dysentery, Bacillary/pathology , Shigella sonnei , Dysentery, Bacillary/epidemiology , Genome, Bacterial/genetics , Humans , Shigella sonnei/classification , Shigella sonnei/genetics , Shigella sonnei/metabolism , Shigella sonnei/pathogenicity , Type III Secretion Systems/genetics , Type III Secretion Systems/physiology , Type VI Secretion Systems/genetics , Type VI Secretion Systems/physiologyABSTRACT
The bacterial pathogen Shigella flexneri causes more than 250 million cases of bacillary dysentery (blood in stool) every year across the world. This human-specific disease is characterized by profuse bloody diarrhea, dramatic ulceration of the colonic epithelium and immune cell infiltration of the colonic tissue. A major challenge in understanding the mechanisms supporting bacillary dysentery is the reliance on animal models that do not fully recapitulate the symptoms observed in humans, including bloody diarrhea. Here we outline advances provided by a recently developed infant rabbit model of bacillary dysentery. The infant rabbit model defines bacillary dysentery as a critical combination of massive vascular lesions and dramatic epithelial fenestration due to intracellular infection and cell-to-cell spread, respectively. The infant rabbit model provides an unprecedented framework for understanding how the cell biology of Shigella flexneri infection relates to pathogenesis.
Subject(s)
Colon/microbiology , Colon/pathology , Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Shigella flexneri/pathogenicity , Animals , Animals, Newborn/microbiology , Colon/immunology , Diarrhea/immunology , Diarrhea/microbiology , Disease Models, Animal , Dysentery, Bacillary/immunology , Guinea Pigs , Humans , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , RabbitsABSTRACT
Human α-defensins are 3- to 5-kDa disulfide-bridged peptides with a multitude of antimicrobial activities and immunomodulatory functions. Recent studies show that human enteric α-defensin 5 (HD5), a host defense peptide important for intestinal homeostasis and innate immunity, aids the highly infectious enteropathogen Shigella in breaching the intestinal epithelium in vitro and in vivo Whether and how HD5 influences Shigella infection of resident macrophages following its invasion of the intestinal epithelium remain poorly understood. Here, we report that HD5 greatly promoted phagocytosis of Shigella by macrophages by targeting the bacteria to enhance bacterium-to-cell contacts in a structure- and sequence-dependent fashion. Subsequent intracellular multiplication of phagocytosed Shigella led to massive necrotic cell death and release of the bacteria. HD5-promoted phagocytosis of Shigella was independent of the status of the type 3 secretion system. Furthermore, HD5 neither inhibited nor enhanced phagosomal escape of Shigella Collectively, these findings confirm a potential pathogenic role of HD5 in Shigella infection of not only epithelial cells but also macrophages, illuminating how an enteropathogen exploits a host protective factor for virulence and infection.
Subject(s)
Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Host-Pathogen Interactions , Shigella/pathogenicity , alpha-Defensins/metabolism , Animals , Bacterial Adhesion , Cells, Cultured , Epithelial Cells/microbiology , Humans , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Macrophages/microbiology , Mice , PhagocytosisABSTRACT
BACKGROUND: Swine dysentery (SD) caused by Brachyspira hyodysenteriae is an important disease in Australia. AIM: The aim of this study is to evaluate the macrolide antibiotic kitasamycin for use in SD control. METHODS: The minimum inhibitory concentrations (MICs) of kitasamycin, tylosin and lincomycin for 32 Australian isolates of B. hyodysenteriae were evaluated. Mutations in the 23S rRNA gene were examined. Isolate '13' with a low kitasamycin MIC was used to challenge weaner pigs. Sixty pigs were housed in 20 pens each containing three pigs: pigs in four pens received 2 kg/tonne of a product containing kitasamycin (3.1% active) prophylactically in their food starting 4 days before B. hyodysenteriae challenge (group 1); pigs in four pens were challenged and received the same dose therapeutically once one pig in a pen showed diarrhoea (group 2); four pens were challenged and received 4 kg/tonne of the product therapeutically (group 3); four pens were challenged but not medicated (group 4); two pens were unmedicated and unchallenged (group 5) and two pens received 2 kg/tonne and were unchallenged (group 6). Pigs were monitored for B. hyodysenteriae excretion and disease. RESULTS: Macrolide resistance was widespread, and mutations in the 23S rRNA gene were identified in 23 isolates. Four isolates with kitasamycin MICs < 5 µg/mL were considered susceptible. Following experimental challenge, 10 of 12 unmedicated pigs developed SD. No pigs receiving kitasamycin prophylactical or therapeutically developed SD. Medicated pigs shed low numbers of B. hyodysenteriae in their faeces. CONCLUSIONS: Kitasamycin can help control SD in pigs infected with susceptible isolates of B. hyodysenteriae.
Subject(s)
Anti-Bacterial Agents/pharmacology , Brachyspira hyodysenteriae/drug effects , Dysentery, Bacillary/veterinary , Gram-Negative Bacterial Infections/veterinary , Kitasamycin/pharmacology , Swine Diseases/drug therapy , Animals , Autopsy/veterinary , Disease Models, Animal , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Genes, rRNA/drug effects , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/pathology , Male , Microbial Sensitivity Tests , Sequence Analysis, RNA , Swine , Swine Diseases/pathology , Western AustraliaABSTRACT
Shigella is the major cause of bacillary dysentery worldwide, especially in developing countries. There are several virulence factors essential for the organism to be virulent which are generally present in the virulence plasmid and on chromosomal pathogenicity islands. The present study was undertaken to determine the virulence gene profile of Shigella spp isolated from a clinical specimen and to study their significant association with common clinical symptoms and antimicrobial resistance. Sixty Shigella whole genome sequences, including 22 S. flexneri, 14 S. sonnei, 17 S. boydii and 7 S. dysenteriae were analyzed for the presence of virulence genes. The gene found predominantly in this study were ipaH (90%) followed by sigA (83%), and lpfA (78%) respectively. The virulence genes were significantly higher in S. flexneri, particularly in serotype 2 compared to S. sonnei. Interestingly, a significant association was observed between sigA gene and fever whereas sepA and sigA were found to be associated with diarrhea. Among the studied Shigella isolates, the presence of virulence genes was found higher in isolates resistant to more than three antibiotic classes. The present work revealed the varying incidence of virulence determinants among different Shigella serogroups and shows their contribution to disease severity.
Subject(s)
Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Feces/microbiology , Genes, Bacterial , Genotype , Shigella/genetics , Virulence Factors/genetics , Dysentery, Bacillary/epidemiology , Incidence , India/epidemiology , Serogroup , Shigella/classification , Shigella/isolation & purification , Shigella/pathogenicityABSTRACT
Intracellular trafficking pathways in eukaryotic cells are essential to maintain organelle identity and structure, and to regulate cell communication with its environment. Shigella flexneri invades and subverts the human colonic epithelium by the injection of virulence factors through a type 3 secretion system (T3SS). In this work, we report the multiple effects of two S. flexneri effectors, IpaJ and VirA, which target small GTPases of the Arf and Rab families, consequently inhibiting several intracellular trafficking pathways. IpaJ and VirA induce large-scale impairment of host protein secretion and block the recycling of surface receptors. Moreover, these two effectors decrease clathrin-dependent and -independent endocytosis. Therefore, S. flexneri infection induces a global blockage of host cell intracellular transport, affecting the exchange between cells and their external environment. The combined action of these effectors disorganizes the epithelial cell polarity, disturbs epithelial barrier integrity, promotes multiple invasion events, and enhances the pathogen capacity to penetrate into the colonic tissue in vivo.
Subject(s)
Dysentery, Bacillary/physiopathology , Intestinal Mucosa/microbiology , Shigella flexneri , Biological Transport , Caco-2 Cells , Cell Polarity , Colon/metabolism , Colon/microbiology , Colon/pathology , Colon/physiopathology , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/pathology , Endocytosis , Humans , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/physiologyABSTRACT
Shigella and enterotoxigenic Escherichia coli (ETEC) are among the top four enteric pathogens that cause diarrheal illness in young children in developing countries and are major etiologic agents of travellers' diarrhoea. A single vaccine that could target both of these pathogens would have significant public health impact. In this review, we highlight the many pivotal contributions of Phillippe Sansonetti to the identification of molecular mechanisms of pathogenesis of Shigella that paved the way for the development of rationally designed, novel vaccines candidates. The CVD developed a series of live attenuated Shigella vaccine strains based on the most prevalent serotypes associated with disease. Shigella vaccine strains were engineered to express critical ETEC antigens to form a broadly protective Shigella-ETEC multivalent vaccine.
Subject(s)
Enterotoxigenic Escherichia coli/immunology , Escherichia coli Infections/immunology , Escherichia coli Vaccines/immunology , Shigella Vaccines/immunology , Shigella/immunology , Diarrhea/microbiology , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/pathology , Enterotoxigenic Escherichia coli/genetics , Enterotoxigenic Escherichia coli/pathogenicity , Escherichia coli Infections/metabolism , Escherichia coli Infections/pathology , Host Microbial Interactions , Humans , Phylogeny , Shigella/genetics , Shigella/pathogenicity , Shigella/ultrastructureABSTRACT
The bacterial pathogen Shigella flexneri causes 270 million cases of bacillary dysentery (blood in stool) worldwide every year, resulting in more than 200,000 deaths. A major challenge in combating bacillary dysentery is the lack of a small-animal model that recapitulates the symptoms observed in infected individuals, including bloody diarrhea. Here, we show that similar to humans, infant rabbits infected with S. flexneri experience severe inflammation, massive ulceration of the colonic mucosa, and bloody diarrhea. T3SS-dependent invasion of epithelial cells is necessary and sufficient for mediating immune cell infiltration and vascular lesions. However, massive ulceration of the colonic mucosa, bloody diarrhea, and dramatic weight loss are strictly contingent on the ability of the bacteria to spread from cell to cell. The infant rabbit model features bacterial dissemination as a critical determinant of S. flexneri pathogenesis and provides a unique small-animal model for research and development of therapeutic interventions.
Subject(s)
Diarrhea/pathology , Dysentery, Bacillary/pathology , Gastrointestinal Hemorrhage/pathology , Shigella flexneri/pathogenicity , Type III Secretion Systems/immunology , Animals , Animals, Newborn/microbiology , Colon/microbiology , Colon/pathology , Diarrhea/microbiology , Disease Models, Animal , Dysentery, Bacillary/microbiology , Epithelial Cells/microbiology , Female , Gastrointestinal Hemorrhage/microbiology , HT29 Cells , Humans , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Pregnancy , RabbitsABSTRACT
Shigella is one of the major enteric pathogens worldwide. We present a murine model of S. flexneri infection and investigate the role of zinc deficiency (ZD). C57BL/6 mice fed either standard chow (HC) or ZD diets were pretreated with an antibiotic cocktail and received S. flexneri strain 2457T orally. Antibiotic pre-treated ZD mice showed higher S. flexneri colonization than non-treated mice. ZD mice showed persistent colonization for at least 50 days post-infection (pi). S. flexneri-infected mice showed significant weight loss, diarrhea and increased levels of fecal MPO and LCN in both HC and ZD fed mice. S. flexneri preferentially colonized the colon, caused epithelial disruption and inflammatory cell infiltrate, and promoted cytokine production which correlated with weight loss and histopathological changes. Infection with S. flexneri ΔmxiG (critical for type 3 secretion system) did not cause weight loss or diarrhea, and had decreased stool shedding duration and tissue burden. Several biochemical changes related to energy, inflammation and gut-microbial metabolism were observed. Zinc supplementation increased weight gains and reduced intestinal inflammation and stool shedding in ZD infected mice. In conclusion, young antibiotic-treated mice provide a new model of oral S. flexneri infection, with ZD promoting prolonged infection outcomes.
Subject(s)
Diarrhea/pathology , Disease Models, Animal , Dysentery, Bacillary/pathology , Shigella flexneri/pathogenicity , Zinc/deficiency , Animals , Anti-Bacterial Agents/administration & dosage , Body Weight , Colon/metabolism , Colon/microbiology , Colon/pathology , Diarrhea/drug therapy , Diarrhea/metabolism , Diarrhea/microbiology , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/microbiology , Feces/enzymology , Feces/microbiology , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Metabolome , Mice, Inbred C57BL , Mutation , Shigella flexneri/genetics , Shigella flexneri/growth & development , Type III Secretion Systems/geneticsABSTRACT
Shigella/Enteroinvasive Escherichia coli (EIEC) pathotype is a major enteropathogen associated with diarrhea and malnutrition in children from developing countries. This study aimed to correlate Shigella/EIEC virulence-related genes (VRGs) with clinical symptoms, nutritional status and coenteropathogens in children from the Brazilian semiarid region. We designed a case-control study of community diarrhea in six cities of the Brazil semiarid region with 1200 children aging 2-36 months. Standardized questionnaire was applied for collecting sociodemographic, nutritional status and clinical information of the children. DNA samples were extracted from stools and diagnosed for Shigella/EIEC using PCR-based approaches. Positive samples were tested for 28 VRGs using four multiplex PCRs. Intestinal inflammation was determined by measuring fecal myeloperoxidase (MPO). Shigella/EIEC pathotype was detected in 5% of the children and was significantly associated with diarrhea. The genes sen (encoding Shigella enterotoxin 2), ipgB2, ipgB1 (both encoding type 3 secretion system-T3SS effectors that modulate actin filament), and ospF (encoding a T3SS effector involved in suppression of host responses) were further associated with diarrhea in Shigella/EIEC positive children. Among children presenting diarrhea, virA gene (encoding a T3SS effector that promotes microtubule destabilization) was associated with fever, while virB (encoding a major transcriptional activator) was associated with low height-for-age z-score. In addition, these VRGs were associated with increased fecal MPO, and coinfection with Salmonella spp. was associated with increased abdominal pain. These data reinforce the impact of Shigella/EIEC on diarrhea in children from Brazilian semiarid region and highlighted the contributions of specific virulence genes for its pathobiology.
Subject(s)
Diarrhea/pathology , Dysentery, Bacillary/pathology , Escherichia coli Infections/pathology , Escherichia coli/isolation & purification , Malnutrition/pathology , Shigella/isolation & purification , Virulence Factors/genetics , Brazil/epidemiology , Case-Control Studies , Child, Preschool , Cities/epidemiology , Cross-Sectional Studies , Desert Climate , Diarrhea/epidemiology , Diarrhea/microbiology , Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Escherichia coli/genetics , Escherichia coli/pathogenicity , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Female , Genes, Bacterial , Humans , Infant , Male , Malnutrition/epidemiology , Malnutrition/microbiology , Polymerase Chain Reaction , Shigella/genetics , Shigella/pathogenicity , Surveys and Questionnaires , Treatment OutcomeABSTRACT
Subversion of antigen-specific immune responses by intracellular pathogens is pivotal for successful colonisation. Bacterial pathogens, including Shigella, deliver effectors into host cells via the type III secretion system (T3SS) in order to manipulate host innate and adaptive immune responses, thereby promoting infection. However, the strategy for subverting antigen-specific immunity is not well understood. Here, we show that Shigella flexneri invasion plasmid antigen H (IpaH) 4.5, a member of the E3 ubiquitin ligase effector family, targets the proteasome regulatory particle non-ATPase 13 (RPN13) and induces its degradation via the ubiquitin-proteasome system (UPS). IpaH4.5-mediated RPN13 degradation causes dysfunction of the 19S regulatory particle (RP) in the 26S proteasome, inhibiting guidance of ubiquitinated proteins to the proteolytically active 20S core particle (CP) of 26S proteasome and thereby suppressing proteasome-catalysed peptide splicing. This, in turn, reduces antigen cross-presentation to CD8+ T cells via major histocompatibility complex (MHC) class I in vitro. In RPN13 knockout mouse embryonic fibroblasts (MEFs), loss of RPN13 suppressed CD8+ T cell priming during Shigella infection. Our results uncover the unique tactics employed by Shigella to dampen the antigen-specific cytotoxic T lymphocyte (CTL) response.
Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Host-Pathogen Interactions , Immune Evasion , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Proteasome Endopeptidase Complex/metabolism , Shigella flexneri/growth & development , T-Lymphocytes, Cytotoxic/immunology , Animals , Cells, Cultured , Cluster Analysis , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Disease Models, Animal , Dysentery, Bacillary/microbiology , Dysentery, Bacillary/pathology , Humans , Lymphocyte Activation , Mice, Inbred C57BL , Mice, Knockout , Models, Theoretical , Phylogeny , RNA, Ribosomal/genetics , Sequence Analysis, DNA , Shigella flexneri/immunology , Shigella flexneri/pathogenicity , T-Lymphocytes, Cytotoxic/microbiology , Virulence Factors/metabolismABSTRACT
While mucosal inflammation is a major source of stress during enteropathogen infection, it remains to be fully elucidated how the host benefits from this environment to clear the pathogen. Here, we show that host stress induced by different stimuli mimicking inflammatory conditions strongly reduces the binding of Shigella flexneri to epithelial cells. Mechanistically, stress activates acid sphingomyelinase leading to host membrane remodeling. Consequently, knockdown or pharmacological inhibition of the acid sphingomyelinase blunts the stress-dependent inhibition of Shigella binding to host cells. Interestingly, stress caused by intracellular Shigella replication also results in remodeling of the host cell membrane, in vitro and in vivo, which precludes re-infection by this and other non-motile pathogens. In contrast, Salmonella Typhimurium overcomes the shortage of permissive entry sites by gathering effectively at the remaining platforms through its flagellar motility. Overall, our findings reveal host membrane remodeling as a novel stress-responsive cell-autonomous defense mechanism that protects epithelial cells from infection by non-motile bacterial pathogens.
Subject(s)
Cell Membrane/immunology , Dysentery, Bacillary/immunology , Epithelial Cells/immunology , Immunity, Innate , Salmonella Infections/immunology , Salmonella typhimurium/immunology , Shigella flexneri/immunology , Stress, Physiological/immunology , Animals , Cell Membrane/pathology , Dysentery, Bacillary/pathology , Epithelial Cells/pathology , Guinea Pigs , Salmonella Infections/pathologyABSTRACT
BACKGROUND: This study aimed to analyze the epidemiological and spatiotemporal characteristics of bacillary dysentery in Zhejiang Province and to provide the basis for its monitoring, prevention and control. METHODS: This study included cases registered in China Information System for Diseases Control and Prevention from 1 January 2005 to 31 December 2017 in Zhejiang. Descriptive methods were employed to investigate the long trend of this disease: gender distribution, high-risk population, seasonality, and circular distribution was explored to detect the peak period; incidence maps were made to show the incidence trend of disease at county level; spatial autocorrelation was explored and the regions with autocorrelation were detected; and spatiotemporal scan was conducted to map out the high-risk regions of disease and how long they lasted. Statistical significance was assumed at p value of <0.05. RESULTS: A total of 105,577 cases of bacillary dysentery were included, the incidence declining sharply from 45.84/100,000 to 3.44/100,000 with an obvious seasonal peak from July to October. Males were more predisposed to the infection than females. Pre-education children had the highest proportion among all occupation categories. Incidence in all age groups were negatively correlated with the year (p < 0.001), and the incidences were negatively correlated with the age groups in 2005â»2008 (p = 0.022, 0.025, 0.044, and 0.047, respectively). Local autocorrelation showed that counties in Hangzhou were high-risk regions of bacillary dysentery. The spatiotemporal scan indicated that all clusters occurred before 2011, and the most likely cluster for disease was found in Hangzhou, Jiaxing and Huzhou. CONCLUSIONS: The incidence of bacillary dysentery in Zhejiang from 2005 to 2017 featured spatiotemporal clustering, and remained high in some areas and among the young population. Findings in this study serve as a panorama of bacillary dysentery in Zhejiang and provide useful information for better interventions and public health planning.
Subject(s)
Dysentery, Bacillary/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , China/epidemiology , Cluster Analysis , Dysentery, Bacillary/pathology , Female , Humans , Incidence , Infant , Male , Middle Aged , Public Health , Retrospective Studies , Risk Factors , Seasons , Young AdultABSTRACT
Shigella is an enteroinvasive human pathogen that infects the colonic epithelium and causes Shigellosis, an infectious diarrheal disease. There is no vaccine for the prevention or treatment of Shigellosis and antibiotic-resistant strains of Shigella are increasing, emphasizing the need for a deeper understanding of Shigella pathogenesis in order to design effective antimicrobial therapies. Small animal models do not recapitulate Shigellosis, therefore tissue-cultured cells have served as model systems to study Shigella pathogenesis. Here, protocols to enumerate Shigella invasion, cell-cell spread, and plaque formation in the tissue-cultured cell lines Henle-407 and CoN-841 are described. Additionally, a new method to study Shigella invasion in primary intestinal enteroids is described. These protocols can be used to examine different aspects of Shigella virulence. © 2018 by John Wiley & Sons, Inc.
Subject(s)
Dysentery, Bacillary/microbiology , Shigella/pathogenicity , Tissue Culture Techniques/methods , Animals , Cell Line , Dysentery, Bacillary/pathology , Humans , Intestines/microbiology , Shigella/genetics , Shigella/physiology , VirulenceABSTRACT
Ca2+ is a ubiquitous ion involved in all known cellular processes. While global Ca2+ responses may affect cell fate, local variations in free Ca2+ cytosolic concentrations, linked to release from internal stores or an influx through plasma membrane channels, regulate cortical cell processes. Pathogens that adhere to or invade host cells trigger a reorganization of the actin cytoskeleton underlying the host plasma membrane, which likely affects both global and local Ca2+ signaling. Because these events may occur at low frequencies in a pseudo-stochastic manner over extended kinetics, the analysis of Ca2+ signals induced by pathogens raises major technical challenges that need to be addressed. Here, we report protocols for the detection of global and local Ca2+ signals upon a Shigella infection of epithelial cells. In these protocols, artefacts linked to a prolonged exposure and photodamage associated with the excitation of Ca2+ fluorescent probes are troubleshot by stringently controlling the acquisition parameters over defined time periods during a Shigella invasion. Procedures are implemented to rigorously analyze the amplitude and frequency of global cytosolic Ca2+ signals during extended infection kinetics using the chemical probe Fluo-4.
Subject(s)
Calcium/metabolism , Dysentery, Bacillary/diagnostic imaging , Epithelial Cells/metabolism , Animals , Dysentery, Bacillary/pathology , Epithelial Cells/pathology , HumansABSTRACT
Disruption of the sumoylation/desumoylation equilibrium is associated with several disease states such as cancer and infections, however the mechanisms regulating the global SUMO balance remain poorly defined. Here, we show that infection by Shigella flexneri, the causative agent of human bacillary dysentery, switches off host sumoylation during epithelial cell infection in vitro and in vivo and that this effect is mainly mediated by a calcium/calpain-induced cleavage of the SUMO E1 enzyme SAE2, thus leading to sumoylation inhibition. Furthermore, we describe a mechanism by which Shigella promotes its own invasion by altering the sumoylation state of RhoGDIα, a master negative regulator of RhoGTPase activity and actin polymerization. Together, our data suggest that SUMO modification is essential to restrain pathogenic bacterial entry by limiting cytoskeletal rearrangement induced by bacterial effectors. Moreover, these findings identify calcium-activated calpains as powerful modulators of cellular sumoylation levels with potentially broad implications in several physiological and pathological situations.
Subject(s)
Calcium/metabolism , Calpain/metabolism , Dysentery, Bacillary/microbiology , Host-Pathogen Interactions , Shigella flexneri/pathogenicity , Ubiquitin-Activating Enzymes/metabolism , Dysentery, Bacillary/metabolism , Dysentery, Bacillary/pathology , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Epithelial Cells/pathology , HeLa Cells , Humans , Proteolysis , Signal Transduction , Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation , rho Guanine Nucleotide Dissociation Inhibitor alpha/metabolismABSTRACT
This paper is about a Brugada syndrome (BS) of accidental discovery in a patient from Benin during an intestinal shigellosis episode in the infectiology department of university hospital of Saint-Etienne, France. Authors establish a link between these two diseases. After a literature's review, they underline that BS is under-diagnosed in Africa. Furthermore, they highlight socio-cultural characteristics of sudden deaths in West Africa including BS.
Subject(s)
Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Dysentery, Bacillary/complications , Dysentery, Bacillary/diagnosis , Benin , Diagnosis, Differential , Dysentery, Bacillary/pathology , Hospitals, University , Humans , Incidental Findings , Male , Medical History Taking , Middle AgedABSTRACT
BACKGROUND & OBJECTIVES: Shigella dysenteriae is one of the most virulent pathogens causing bacillary dysentery and is responsible for high mortality in infants. To reduce the load of antibiotic therapy for treating shigellosis, this study was carried out to assess the ex vivo effect of novel probiotic lactobacilli, isolated from infant's stool samples, on killing S. dysenteriae type 1 residing in the rat macrophages. METHODS: Stool samples from infants were collected, processed for the isolation of lactobacilli and screened for the probiotic attributes (acid tolerance, bile tolerance, ability to adhere intestinal cells and anti-S. dysenteriae activity). The effect of cell-free supernatant of lactobacilli on Shigella- infected macrophages in terms of phagocytic ability, extent of lipid peroxidation, nitrite, superoxide dismutase and glutathione levels was evaluated. RESULTS: Based on the probiotic attributes, three lactobacilli were isolated from the stool samples of infants. Using classical and molecular tools, these isolates were identified as Lactobacillus pentosus, L. Paraplantarum and L. rhamnosus. All the three lactobacilli had the ability to kill intramacrophage S. dysentriae type 1. The anti-Shigella activity of the probiotic lactobacilli was attributed to increased antioxidative ability and decreased free radical production by the infected macrophages. INTERPRETATION & CONCLUSIONS: Probiotic cocktail of L. pentosus, L. paraplantarum and L. rhamnosus showed ex vivo killing of S. dysenteriae residing inside the rat macrophages significantly. This cocktail has the potential to be used as a natural alternative for treating S. dysenteriae infection, especially in infants, however, further studies need to be done to confirm these finding in vivo.